You are here

Comment

Discuss

What’s The Stem Cells Buzz This Week? - Unraveling Kidney Disease with hPSC-Podocytes, Regulation of YAP1 Expression in Osteosarcoma, a New Dry AMD iPSC-Model, and BMSC Study Finds No Endometrial Contribution!

The Stem Cells Portal brings you a roundup of some of the new and exciting stories in the ever-changing world of stem cells, regenerative medicine, and beyond!

‘Epigenetic’ changes from cigarette smoke may be first step in lung cancer development

Scientists at the Johns Hopkins Kimmel Cancer Center say they have preliminary evidence in laboratory-grown, human airway cells that a condensed form of cigarette smoke triggers so-called “epigenetic” changes in the cells consistent with the earliest steps toward lung cancer development.

India and Japan sign agreement to collaborate on stem cell research

India’s Department of Biotechnology announced that it has implemented a cooperative program with Japan to accelerate the application of stem cell technology in human disease with four institutions from India participating with the Centre for iPS Cell Research and Application (CiRA), Kyoto University, Japan, as international partner.

Antibody study suggests better way to reprogram stem cells

Scientists at the Scripps Research Institute (SRI) have found a new approach to the “reprogramming” of ordinary adult cells into stem cells.

In a study published early online in Nature Biotechnology, the scientists screened a library of 100 million antibodies and found several that can help reprogram mature skin-like cells into stem cells known as induced pluripotent stem cells (IPSCs).

What’s the Stem Cells Buzz this Week? - MSCs for Clinical Trials, MSC-Exosomes in Cancer Progression, Evolution of Glioblastoma Stem-Like Cells, and WJ-MSC Differentiation to Osteoblasts!

The Stem Cells Portal brings you a roundup of some of the new and exciting stories in the ever-changing world of stem cells, regenerative medicine, and beyond!

TEC-mediated FGF2 Secretion Controls hPSC Pluripotency

A new study describes the discovery of a novel regulator of basic fibroblast growth factor 2-mediated pluripotency

Is an Extracellular Matrix Component the Key to Adult Cardiac Regeneration?

A new study finds that the extracellular matrix component Agrin promotes adult cardiac regeneration in a mouse model of heart disease

FDA grants orphan drug status to Cellect's Apograft for acute GVHD and chronic GVHD

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation for Cellect Biotechnology Ltd.'s ApoGraft™ for the prevention of acute and chronic graft versus host disease(GvHD) in transplant patients. Cellect is a developer of stem cells selection technology.

What’s the Stem Cells Buzz this Week? - Kidney Generation with hPSCs, hPSC Hematopoietic Differentiation, LeX-SSEA1 in NSCs, and Allogeneic ASCs for Heart Disease!

The Stem Cells Portal brings you a roundup of some of the new and exciting stories in the ever-changing world of stem cells, regenerative medicine, and beyond!

New model for hard-to-study form of blindness paves way for future research

Macular degeneration is the leading cause of vision loss in older adults, but scientists have long struggled to study and replicate key elements of the disease in the lab. A study published in the Proceedings of the National Academy of Sciences is the first to demonstrate hallmarks of macular degeneration in a new human stem cell model developed by researchers at the University of Rochester Medical Center. 

Pages

Subscribe to Stem Cells Portal - Stem Cells Journal Online Community RSS